Presented to recognize successful commercialization of innovation in Canada, in the field of Bio-medical Science and Engineering, with a particular focus on the synergistic relationship between university and business.
The 2017 winner of the Julia Levy Award is:
Cresswell Advisors Inc.
David Allan is the Principal at Cresswell Advisors Inc.
He was the founding and sunset chair of YM BioSciences Inc., and CEO from 1998-2011; founding chair of Formation Biologics; executive chair of Stem Cell Therapeutics (now Trillium Therapeutics). He has been a member of the awards selection committee of Canada’s Networks of Centres of Excellence and the multidisciplinary assessment committee of the Canada Foundation for Innovation. He was formerly a governor of the Toronto Stock Exchange and, 1992, founded the first biotech-specific investment banking team in Canada.
He is the recipient of the 2016 Life Sciences Ontario Leadership Award and the 2012 Gold Leaf Award from BIOTECanada, YM BioSciences Inc, in 1994 and has been chair of the board of directors since incorporation and serving as chief executive officer from 1998 through 2010. He became chair of Stem Cell Therapeutics following completion of the acquisition of Trillium Therapeutics in 2013 and is the chair of AvidBiologics, a Canadian joint venture with National Research Council of Canada developing antibody-drug-conjugates. Allan was also the lead director of DiaMedica Inc. (diabetes therapeutics) and a number of private companies.
In the final decade of a 35-year career in investment banking he founded the first Canadian investment banking and research team specializing in the life sciences.
Allan is also a founding and sunset chair of the Toronto Stock Exchange Market Access Implementation Committee that created access for small and medium-sized enterprises to Canada’s principal capital market and was a member, and working group chair of the Ontario Biotechnology Advisory Board. He has been a board member of the Shaw Festival Theatre and of the board of trustees for the Ontario College of Art and Design. Allan is currently a member of BIOTECanada's Emerging Companies Advisory Board, and is a member of the board of directors of Life Sciences Ontario, both biotechnology industry organizations.